Cheng-Wei Liu

Title: Cheng-Wei Liu: Innovator in Cancer Detection Technology

Introduction

Cheng-Wei Liu is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of cancer detection, particularly through his innovative work on lysyl oxidase-like 2 protein (LOXL2). His research aims to enhance the accuracy of breast cancer diagnostics.

Latest Patents

Cheng-Wei Liu holds a patent for a "System and method for detecting lysyl oxidase-like 2 protein (LOXL2) and breast cancer." This detection system is designed to determine LOXL2 levels in bodily samples. It includes at least one reaction solution that generates hydrogen peroxide (HO) in combination with LOXL2. The reaction solution contains lysine, which can be oxidatively deaminated by LOXL2 to produce α-aminoadipic-δ-semialdehyde (allysine) and hydrogen peroxide.

Career Highlights

Cheng-Wei Liu is affiliated with Case Western Reserve University, where he continues to advance his research in cancer detection technologies. His work has the potential to significantly impact the early diagnosis and treatment of breast cancer.

Collaborations

Cheng-Wei Liu collaborates with esteemed colleagues, including Chung-Chiun Liu and Yuan Zhang. Their combined expertise contributes to the development of innovative solutions in the field of cancer research.

Conclusion

Cheng-Wei Liu's contributions to cancer detection technology exemplify the importance of innovation in medical research. His work not only enhances diagnostic capabilities but also holds promise for improving patient outcomes in breast cancer treatment.